P. Zintl

Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer

Andrés Poveda, Stanley B. Kaye, Robert McCormack et al. · Gynecologic Oncology · 2011 · 176 citations

Medicine, Pathology, Gynecology +8

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy

Nicolas Penel, George D. Demetri, Jean‐Yves Blay et al. · Annals of Oncology · 2012 · 50 citations · Full text

Salvage Therapy, Oncology, Medicine +3

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours

Cristiana Sessa, Sara Cresta, Cristina Noberasco et al. · European Journal of Cancer · 2009 · 33 citations

Malignant Disease, Medicine, Pharmacology +7

Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials

José María Del Campo, Cristiana Sessa, Carolyn Krasner et al. · Medical Oncology · 2013 · 32 citations

Gynecological Surgery, Single Agent, Medicine +8

Phase I and Pharmacokinetic Study of Trabectedin as a 1- or 3-hour Infusion Weekly in Patients with Advanced Solid Malignancies

Bahram Forouzesh, Manuel Hidalgo, Quincy Chu et al. · Clinical Cancer Research · 2009 · 28 citations · Full text